Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2838 of 5804
-
New program aims to ease financial burden for cancer patients
Symptom relief CompletedThis study is a randomized clinical trial designed to test a novel financial navigation intervention. The study assesses the impact of the financial navigation intervention on financial hardship and health-related quality of life, cancer-related material and psychological financi…
Phase: NA • Sponsor: Kaiser Permanente • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
New cough drug shows promise in early trial
Symptom relief CompletedThis is a randomized, double-blind, placebo-controlled, crossover, multicenter study of AX-8 in participants with unexplained or refractory chronic cough designed to evaluate the effectiveness of AX-8 in reducing cough frequency.
Phase: PHASE2 • Sponsor: Axalbion SA • Aim: Symptom relief
Last updated Jun 26, 2026 14:31 UTC
-
Paws and play: can animal training boost resilience in kids?
Symptom relief CompletedThe goal of this clinical trial is to learn about the effects of an animal-assisted resilience training in children who experienced stressful life events or who have a diagnosis of autism spectrum disorder. The main question it aims to answer is: • Is an animal-assisted resilien…
Phase: NA • Sponsor: University Hospital, Basel, Switzerland • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
New study aims to uncover hidden kidney risks in type 2 diabetes patients
Knowledge-focused Recruiting nowa prospective, observational, multi-center study with a cohort of 300 patients with Type 2 diabetes and macroalbuminuria. Prospectively we will collect kidney biopsies and analyse the transciptome of the kidney tissue and other biomarkers from blood, faeces, urine, proteomic- and…
Sponsor: Herlev Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
New combo therapy for mesothelioma shows early promise
Disease control OngoingThe purpose of this study is to find out whether IMPRINT in combination with pembrolizumab is a safe treatment for people with malignant pleural mesothelioma (MPM).The highest dose of IMPRINT that causes few or mild side effects when given in combination with pembrolizumab will b…
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Brain zap study reveals how DBS shapes impulse control in Parkinson's
Knowledge-focused Recruiting nowPatients with Parkinson's Disease will be studied before, during, and after a deep brain stimulation implantation procedure to see if the stimulation location and the size of the electrical field produced by subthalamic nucleus (STN) DBS determine the degree to which DBS engages …
Phase: PHASE4 • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
New program helps men beat diabetes risk
Prevention CompletedThe goal of this study is to address the risk of diabetes among men by creating a Diabetes Prevention Program (DPP) tailored to men.
Phase: NA • Sponsor: Albert Einstein College of Medicine • Aim: Prevention
Last updated Jun 27, 2026 12:02 UTC
-
Immune booster after CAR-T shows promise in early lymphoma trial
Disease control CompletedThis is a multicenter Phase 1b study evaluating the safety, tolerability, and preliminary anti-tumor activity of NT-I7 administration following standard of care CD19 CAR T-cell therapy for eligible subjects with r/r LBCL.
Phase: PHASE1 • Sponsor: NeoImmuneTech • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New kidney anemia drug under Long-Term safety review
Disease control OngoingIn this study, the researchers want to learn more about the safety and effectiveness of Molidustat in Japanese men and women who have renal anemia, a condition in which the kidneys do not make enough of a hormone that helps the body make new red blood cells. In previous clinical…
Sponsor: Bayer • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Heart scans after COVID shot: new study aims to uncover hidden risks
Knowledge-focused OngoingThe study will focus on cardiac blood and imaging biomarkers to facilitate early recognition of patients at risk for myocardial injury after COVID-19 vaccination. Ultimately, the intention is to identify patients at risk, reduce adverse events, and determine the need for longer-t…
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New drug combo targets tough cancers in early trial
Disease control OngoingThe purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary efficacy of KIN-2787 in adults with BRAF/NRAS-mutated advanced or metastatic solid tumors.
Phase: PHASE1 • Sponsor: Pierre Fabre Medicament • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Exercise may sharpen aging brains after depression
Knowledge-focused CompletedCognitive impairment and brain abnormalities are common and persist after depression remission in those with Late Life Depression (LLD), compounding dementia risk in both individuals with acute and remitted LLD (rLLD). In this study, investigators will examine systemic neural and…
Phase: NA • Sponsor: University of Pittsburgh • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
Can group nutrition classes help african american women tame diabetes?
Disease control OngoingA two-arm randomized controlled trial design will be used. Participants will include 291 African American women with type 2 diabetes that are at risk for development and/or progression of diabetes complications. Both arms, diabetes medical nutrition therapy (MNT) and diabetes MNT…
Phase: NA • Sponsor: Meharry Medical College • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New RNA cocktail takes on advanced liver cancer in early trial
Disease control OngoingThis is a single-center, phase 1, open label, dose-escalation study of MTL-CEBPA co-administered with atezolizumab and bevacizumab to assess the PK, PD, and potential toxicities of the drug combination in advanced HCC patients, and to determine the MTD, OBD or RP2D. The sample si…
Phase: PHASE1 • Sponsor: National University Hospital, Singapore • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Tech program aims to slash soda intake in appalachia
Disease control CompletedThe proposed randomized controlled trial (RCT) is guided by the RE-AIM (i.e. reach, efficacy, adoption, implementation, maintenance) framework and targets 244 adults from rural Appalachia. The overall goal is to examine the efficacy of iSIPsmarter in a 2 group \[iSIPsmarter vs. s…
Phase: NA • Sponsor: University of Virginia • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New tool helps kids with cancer speak up about symptoms
Symptom relief CompletedMost children with cancer survive because they are given intensive treatments, but unfortunately, these treatments are associated with distressing symptoms. To address this problem, we developed the Symptom Screening in Pediatrics Tool (SSPedi) so that children receiving cancer t…
Phase: NA • Sponsor: The Hospital for Sick Children • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Virtual reality could ease stress for children facing cancer radiation
Symptom relief Recruiting nowFor a young patient, the conditions of proton therapy treatment can be stressful. Adjusting the environment can be a source of avoiding this physical and psychological discomfort impacting the quality of treatment. A fixed, long, uncomfortable position is the main cause of stres…
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Liver-Directed drug combo shows promise for rare eye cancer
Disease control TerminatedThis study is an open-label, phase 1/1b study of the pressure-enabled hepatic artery infusion of SD-101, a TLR 9 agonist, alone or in combination with intravenous checkpoint blockade in adults with metastatic uveal melanoma.
Phase: PHASE1 • Sponsor: TriSalus Life Sciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New app helps people with mental illness shed pounds
Disease control CompletedThis project addresses obesity in the population with SMI by evaluating a weight management program that is not only evidence-based, it is sustainable, transportable, appealing to patients, easy to use, and minimally burdensome to the healthcare system. This effort addresses two …
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Mindfulness may boost opioid treatment success
Disease control CompletedThis proposal aims to determine whether an adjunctive Mindfulness-Based Relapse Prevention (MBRP) treatment program improves Medication Assisted Treatment (MAT) adherence and reduces drug-use among opioid use disorder (OUD) patients. The broad long-term objectives of this project…
Phase: NA • Sponsor: West Chester University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC